The FAM161A gene helps the light sensing cells in the retina keep their inner structure stable so they can continue sending visual signals. This gene plays an important role in how these cells maintain the tiny transport system they need to survive. When both copies carry a harmful variant, the retina can slowly wear down, most often causing retinitis pigmentosa. People may first notice trouble seeing in dim light, then a narrowing of side vision, and later more difficulty with detailed central sight.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or managing processes throughout the body. Some genes carry the code for proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a deeper look at this topic, you can visit the LearnHub.
Overview
FAM161AGene function
What if the gene works
The FAM161A gene helps organize tiny support fibers in retinal light sensing cells. This supports a small transport structure that moves materials the cells need to work and stay healthy.
Risk
What if the gene does not work
Variants in the FAM161A gene most often cause inherited retinal degeneration, especially retinitis pigmentosa. Vision may decline from night blindness and side vision loss to broader impairment, with milder or more severe variants influencing how early changes begin and how pronounced they are.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the FAM161A gene, no FAM161A-specific treatment or drug selection approach is currently established in clinical guidelines. The FAM161A gene is being studied in early-stage retinal gene replacement research, but this has not yet changed routine care.
Conditions associated with FAM161A
Gene function
What if the gene works
Your cells use the FAM161A gene to support the internal framework that keeps certain cell parts steady. This matters most in the retina, where light sensing cells depend on a slim bridge called the connecting cilium. Understanding this role makes it easier to see how these cells keep needed materials moving to the right place.
Inside many cells, the FAM161A gene helps organize microtubules, the thin support fibers that shape cells and guide movement inside them. This helps keep important structures aligned and stable.
Its protein gathers at the centrosome and the base of cilia, the tiny hair-like projections some cells use for sensing and transport. There, it helps maintain the cilium's structure and supports smooth movement of materials.
In the retina, the FAM161A gene supports the connecting cilium, a narrow bridge inside light sensing cells. This bridge helps shuttle proteins between cell compartments, which is central to how the FAM161A gene works in retinal light sensing cells.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the FAM161A gene make the FAM161A protein too short, unstable, or unable to reach the light sensing cells where it is needed, which helps explain how FAM161A variants affect protein function. More disruptive variants, such as stop, frameshift, or some splice changes, often lead to little or no working protein. Milder variants may leave some activity, which can be linked to later onset or slower progression of inherited retinal disease.
How variants are linked to conditions
Pathogenic variants in the FAM161A gene cause an inherited eye condition called autosomal recessive retinitis pigmentosa. This is the clearest example of how FAM161A gene variants are linked to inherited retinal conditions. In most people, the diagnosis is confirmed when pathogenic variants are found in both copies of the gene, while carrying one variant usually does not cause the condition.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For FAM161A, risk is mainly shaped by the variants inherited in the family rather than by lifestyle. People usually develop related vision loss only if they inherit a nonworking copy from both parents, so family history and whether a partner also carries a FAM161A variant can change risk.
Inheritance of FAM161A variants
For families asking about inheritance of the FAM161A gene variants, the well-established pattern is autosomal recessive. This means a person usually inherits one FAM161A variant from each parent, and the parents are typically healthy carriers. When both parents carry a variant in the FAM161A gene, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is a carrier, and a 25% chance of a child who inherits neither variant. Mothers and fathers pass these variants on equally.
What does my FAM161A result mean for my family?
For families with a disease-causing change in the FAM161A gene, close relatives may also carry the same change, even if they have no vision symptoms. This condition is usually passed down in a recessive pattern, so brothers, sisters, and future children may be affected or be carriers depending on the changes they inherit. Family members may want to discuss their own chance of carrying the gene change with a genetics professional.
Genetic information
Genetic testing
How you find out about variants
FAM161A genetic testing usually uses a blood or saliva sample to look for variants linked with inherited retinal conditions. A lab reads the FAM161A gene and compares it with the usual sequence. Results may show a disease-causing variant, no relevant variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the FAM161A gene may be worth considering if you or your child has inherited vision loss such as retinitis pigmentosa, especially with night blindness or slowly narrowing side vision. It can also help when this kind of eye condition runs in the family or when a relative is known to carry a FAM161A change.
A genetic result is only one part of your health story
Genetic test results can be informative, but what they tell you depends on the condition and on the specific type of variant involved. Over time, factors such as lifestyle, environment, age, and medical history also influence how the body functions. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than another. This is common and can influence both benefit and side effects, including how sensitive someone is to a usual dose.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that focuses on how genetic differences affect medication response. It examines relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can help support treatment decisions that are more informed and more individualized. If you want to explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the FAM161A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so general health concerns and any questions about medication benefits or side effects are best discussed with your doctor. If your eye symptoms change, or a new treatment is being considered, your doctor or eye specialist can help guide next steps.
History
For years, clinicians recognized inherited retinal disease in some families before the exact cause was known. In the 2000s, researchers mapped one form of retinitis pigmentosa to a region on chromosome 2, and this work later led to the identification of the FAM161A gene as the cause in affected families. Early reports drew particular attention to families of Jewish ancestry, where a recurring founder variant helped clarify the inheritance pattern. From these first observations, research expanded steadily, and FAM161A became part of the growing list of genes linked to inherited vision loss. Its discovery helped refine genetic diagnosis for people with retinitis pigmentosa and related retinal conditions.